Inslee appoints representatives to multi-state COVID vaccine workgroup

Story Body

Gov. Jay Inslee today announced that Dr. Ed Marcuse and Dr. John Dunn will represent Washington in the multi-state COVID Vaccine Scientific Safety Review Workgroup. Inslee announced the Western state workgroup in October in coordination with California, Oregon and Nevada.

"I have no doubt that Dr. Marcuse and Dr. Dunn will be excellent additions to this workgroup and give Washingtonians confidence that any vaccine will be rigorously reviewed and ready for safe and reliable delivery," Inslee said. "Together, their experience and expertise represent the best of our state and I know they will add a tremendous amount of knowledge to this very important workgroup."

Dr. Ed Marcuse is an emeritus professor of pediatrics at the University of Washington. He has served as a member and chair of the U.S. National Vaccine Advisory Committee, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practice and the Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee, among others. He has also authored over 150 publications, including studies on immunization.

He obtained his doctor of medicine degree from Stanford Medical School and master of public health from the University of Washington.

Dr. John Dunn is the medical director of preventive care and clinical lead for immunization population management at Kaiser Permanente Washington as well as working as an evidence-based medicine methodologist. He has extensive experience in developing preventive care guidelines for Kaiser Permanente and advising vaccine safety studies and is a member of the Health and Human Services (HHS) National Vaccine Advisory Committee.

He obtained his doctor of medicine degree from Northwestern University and master of public health from Harvard University School of Public Health.

Background: Inslee announces Western states workgroup to ensure safety and efficacy of COVID vaccines

Media Contacts

Public and constituent inquiries | 360.902.4111
Press inquiries | 360.902.4136